CTRI/2021/10/037369尚未招募未知
A Randomized,case controlled open label study to evaluate safety and efficacy of prucalopride with PEG versus PEG alone for colonoscopy preparation
Dr RPGMC kangra at Tanda0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •All patients in age group 18-75 years coming for colonoscopy
排除标准
- •1. Uncooperative patients/Non Consenting
- •2. Known or suspected colonic perforation
- •3. Severe toxic megacolon and fulminant colitis
- •4. Clinically unstable patients
- •5. Recent myocardial infarction
- •6. Renal dysfunction
- •7. Known Hypersensitivity to study drugs
- •8. Pregnant Females
研究者
相似试验
进行中（未招募）
不适用
An open label randomised controlled study to compare the efficacy, safety and tolerability of once every four weeks administration of subcutaneous C.E.R.A. versus darboepoetin alfa for the maintenance of haemoglobin levels in predialysis patients with chronic renal anaemia.Estudio abierto, randomizado, controlado para comparar la eficacia, seguridad y tolerancia de la administración una vez cada cuatro semanas de C.E.R.A. por vía subcutánea frente a darbepoetina alfa para el mantenimiento de las concentraciones de hemoglobina en pacientes con anemia renal crónica que no están en diálisis.Anemia en insuficiencia renal crónicaMedDRA version: 9.1Level: LLTClassification code 10058124Term: Nephrogenic anemiaEUCTR2007-001904-18-ESROCHE FARMA S.A.
进行中（未招募）
不适用
A Randomized, Controlled, Open- label Study Evaluating the Efficacy and Tolerability of AMG 531 versus Medical Standard of Care as Chronic Therapy for Non-splenectomized Subjects with Immune (Idiopathic) Thrombocytopenic PurpuraEUCTR2006-003700-18-ATAmgen Inc.210
进行中（未招募）
1 期
A Randomized, Controlled, Open- label Study Evaluating the Efficacy and Tolerability of AMG 531 versus Medical Standard of Care as Chronic Therapy for Non-splenectomized Subjects with Immune (Idiopathic) Thrombocytopenic PurpuraImmune (idiopathic) thrombocytopenic purpura (ITP)MedDRA version: 8.1Level: PTClassification code 10021245Term: Idiopathic thrombocytopenic purpuraEUCTR2006-003700-18-BEAmgen Inc.210
进行中（未招募）
1 期
A Randomized, Controlled, Open- label Study Evaluating the Efficacy and Tolerability of AMG 531 versus Medical Standard of Care as Chronic Therapy for Non-splenectomized Subjects with Immune (Idiopathic) Thrombocytopenic PurpuraImmune (idiopathic) thrombocytopenic purpura (ITP)MedDRA version: 8.1Level: PTClassification code 10021245Term: Idiopathic thrombocytopenic purpuraEUCTR2006-003700-18-GBAmgen Inc.210
进行中（未招募）
1 期
A Randomized, Controlled, Open- label Study Evaluating the Efficacy and Tolerability of AMG 531 versus Medical Standard of Care as Chronic Therapy for Non-splenectomized Subjects with Immune (Idiopathic) Thrombocytopenic PurpuraImmune (idiopathic) thrombocytopenic purpura (ITP)MedDRA version: 8.1Level: PTClassification code 10021245Term: Idiopathic thrombocytopenic purpuraEUCTR2006-003700-18-FRAmgen Inc.210